Operating profit before amortization: Inogen, Inc. (INGN)

Public company logo of Inogen (INGN)

Low geopolitical risks and the availability of products in global markets ensure the stability of Inogen, Inc. (INGN). Quarterly EBITDA volume on this GURU.Markets platform chart confirms this resilience, where the parameter value equals 0.00. The business relies on direct sales and service contracts, while the integration of portable systems with remote monitoring creates a comprehensive support environment, firmly anchoring patients to the brand.

Inogen (INGN) Profit before payment of interest, taxes and amortization: for the period 11/23/2025 - 11/10/2026

Summary analytical data breakdowns for Inogen (INGN)

- market price and analyst price targets:
Stock Price Inogen Inc|INGN - Price Target Chart
- company stock exchange capitalization indicators:
Market Capitalization Inogen, Inc.|INGN - Enterprise Value
- balance sheet net asset value indicators:
Net Asset Value per Share Inogen, Inc.|INGN - Company Book Value|Market-to-Book Ratio inogen.com|INGN - Cumulative Company Assets
- business debt structure and liquidity details:
Total Debt to Capital Inogen, Inc.|INGN - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Inogen Inc|INGN - Company Total Debt|Debt to Net Assets Ratio Inogen, Inc.|INGN - Company Long-Term Debt|Company Current Liabilities Inogen, Inc.|Immediate Liquidity inogen.com
- earnings and market multiples details:
INGN - Net Profit|Net Profit Forecast Inogen, Inc.|INGN - P/E Multiple|Market Cap to Projected Earnings Inogen Inc|INGN - PEG Multiple|Enterprise Value to EBITDA Ratio Inogen, Inc.|INGN - Operating profit EBITDA|Net earnings per share (EPS TTM) Inogen, Inc.|INGN - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months inogen.com|INGN - Net earnings per share growth this year|Expected earnings per share trend next year Inogen, Inc.
Fundamental company valuation:Inogen, Inc.
Original product of Inogen, Inc.

This indicator is calculated as operating profit adjusted for non-cash expenses, which eliminates the impact of depreciation and accounting adjustments on actual cash flow. EBITDA cash flow stability is currently critical for Inogen, Inc. (INGN) amid pricing pressure from Asian competitors, as the transition to subscription-based service models should stabilize this metric and prevent capital stagnation.

Competitors of Inogen, Inc. (INGN)

Operating profit EBITDA Stryker Corporation Inc. SYK|MDT - Profit before payment of interest, taxes and amortization|PHG (philips.com) - Operating profit before amortization|SNN: Operating profit EBITDA|Profit before interest, taxes and amortization Hologic Inc (HOLX)|Profit before payment of interest, taxes and amortization Carlisle Companies Inc.|Profit before interest, taxes and amortization Integer Corp ITGR|Operating profit before deduction of amortization LIVN (LivaNova PLC)|Operating profit EBITDA adapthealth.com (AHCO)|Profit before payment of interest, taxes and amortization SS Innovations International Inc SSII|Operating income before deduction of amortization Avanos (AVNS)|SI: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization VMD (Viemed Inc)|owletcare.com (OWLT) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization quipthomemedical.com|POCI (Precision Optics Corp) - Operating profit EBITDA|Profit before interest, taxes and amortization PAVmed Inc PAVM|Operating profit EBITDA TIVC|Movano Corp - Operating profit before amortization|Operating profit EBITDA NUVO (Holdco Nuvo Group D.G Ltd)